Fear of progression and associated factors in glaucoma patients: a latent profile analysis Authors: Chunyan Yang, Shenyi Chen, Suihua Zhong, Yuyao Ling, Xiaoxin Guo, Weixin Zheng, Yiqing Li, Yu Zhang Published: 2026 ABSTRACT BackgroundFear of progression (FoP) is patients’ fear of the illness progression or exacerbation and occurs in numerous chronic diseases, leading to poor quality of life. Glaucoma patients, who suffer from chronic and progressive visual impairment, are at high risk of developing fears such as falling or blindness. However, FoP has received limited attention in glaucoma population. This study aimed to identify patterns of FoP in glaucoma patients and explore the relationship between FoP, glaucoma symptoms, illness perception, as well as socio-demographic and clinical factors, thereby improving personalized health care in glaucoma patients.MethodsConvenience sampling method was used to select glaucoma patients. A sample of 227 glaucoma patients completed relevant questionnaires, which included sections on the socio-demographic and clinical information questionnaire, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF), the Glaucoma Symptom Scale Questionnaire and the Brief Illness Perception Questionnaire. Latent profile analysis was performed using the scores from the 12 items of the FoP-Q-SF, while univariate and ordinal logistic regression analyses were used for statistical evaluation.ResultsThree FoP groups were identified: low FoP-supported group (21.14%), moderate FoP-stable group (47.58%), and high FoP-uncertain group (31.28%). Middle age (OR = 2.971, 95% CI = 1.071–8.240), unemployment (OR = 2.560, 95% CI = 1.203–5.441), being married (OR = 2.342, 95% CI = 1.053–5.202), a worse VF MD in their worse eye (OR = 0.969, 95% CI = 0.942–0.996) and higher levels of illness perception (OR = 1.040, 95% CI = 1.011–1.069) were more likely to experience higher FoP.ConclusionThe findings emphasize the importance of identifying distinct FoP profiles in glaucoma patients, particularly among those in the high FoP group. Factors such as middle age, unemployment, being married, more severe visual field damage, and perceived illness burden are closely linked to higher FoP levels. Healthcare providers can implement more tailored interventions that address the psychological needs of glaucoma patients, ultimately reducing their FoP.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s40359-026-04979-4. Introduction Glaucoma is a chronic disease characterized by optic nerve damage and progressive visual-field loss [1]. It is a leading cause of irreversible blindness, affecting approximately 95 million individuals, including 7 million with bilateral blindness [2, 3]. Current management focuses on lowering intraocular pressure (IOP) through medications, laser therapy, or surgery to slow disease progression. However, these approaches cannot reverse existing damage or fully prevent vision loss. Treatment adherence remains a significant challenge, as effective care requires regular monitoring. Combined with uncertainty about treatment outcomes, many patients experience prolonged psychological stress, such as anxiety and depression [4–7]. Previous studies have linked these mental burdens to impaired daily activities and the concern of potential blindness [8, 9]. Fear of progression (FoP) is defined as patients’ fear of the illness progression or exacerbation with all its biopsychosocial consequences [10]. Unlike anxiety and depression, FoP specifically focuses on the fear of functional decline and treatment failure related to disease progression. Initially recognized in cancer patients, FoP affects nearly 50% of cancer survivors [11], with many experiencing a moderate or severe level of this fear [10]. Emerging evidence shows that FoP is also prevalent in other chronic conditions, such as multiple sclerosis and diabetes [12, 13], underscoring the importance of addressing FoP across patients with chronic diseases. Previous studies have identified multiple factors influencing FoP, including younger age, socioeconomic status, unemployment, social support, and illness perception [14–16]. Despite its recognized impact, research on FoP in glaucoma patients is scarce. Existing studies have mainly focused on specific fears, such as fear of falling and fear of blindness, both of which are common and may be closely related to FoP [17–19]. Therefore, investigating FoP and its underlying factors is essential for a more comprehensive understanding of how glaucoma patients cope with disease progression. Traditional methods of studying FoP often categorize patients into “functional” and “dysfunctional” groups based on questionnaire scores. While this approach is helpful, it ignores the heterogeneity of the patients. To identify distinct and clinically meaningful subgroups with a heterogeneity sample, Latent Profile Analysis (LPA) was employed to address this gap by investigating the psychological profiles of FoP in glaucoma patients [20, 21]. LPA is a person-centered approach that identifies subgroups based on shared characteristics, using objective model fit indices to determine the optimal number of profiles. LPA has been successfully applied in cancer research to identify patterns in social constraints and other factors affecting patient experiences. In this study, we used LPA to classify glaucoma patients into distinct profiles based on their responses to the Fear of Progression Questionnaire and explore the sociodemographic and clinical factors associated with each profile, thereby informing more targeted psychosocial interventions to better address FoP in glaucoma patients. The Common Sense Model of Self-Regulation (CSM) is a health behavior theory that suggests individuals facing health threats develop cognitive and emotional perceptions of their condition. These perceptions significantly influence patients’ psychological responses, such as fear, depression and anxiety, which, in turn, impact their coping behaviors, including treatment adherence [22]. In glaucoma, patients’ perceptions may play a critical role in shaping their emotional responses and coping strategies. Based on the CSM, we hypothesized that sociodemographic and disease-related characteristics, together with glaucoma symptoms and illness perception, were associated with the FoP. This study aimed to explore the profiles of FoP and identify the factors influencing FoP in glaucoma patients. Understanding these factors will help pinpoint areas where interventions can be implemented to alleviate FoP and improve patient outcomes. Methodology Aims The study aimed to investigate the FoP and its correlation factors in glaucoma patients. Design This was a cross-sectional observational study, and convenience sampling was conducted from April to November 2024. A cohort of 227 participants were recruited from one hospital in China. Sampling and inclusion criteria Participants were included if they met the following criteria: (1) age 18 or older; (2) a diagnosis of glaucoma based on a comprehensive ophthalmic evaluation, including optic nerve head, visual field, and anterior segment assessment [23, 24]; (3) proficiency in Mandarin for comprehension and communication. Exclusion criteria included: (1) mental disorders and cognitive impairment; (2) comorbid ocular conditions, such as cataract or retinal diseases. The sample size was calculated using the formula n = (Uα/2/δ)2p(1-p), where Uα/2 = 1.96, δ = 0.065 and p = 0.70. These parameters were derived from the proportion of FoP dysfunction observed in our pre-test study, which yielded an initial estimate of 191 participants. However, considering a potential nonresponse rate of 10% and invalid questionnaires, the minimum required sample size was increased to at least 210 participants. Consequently, a convenience sampling approach was employed to recruit eligible participants until this requirement was satisfied. Ultimately, 227 valid questionnaires were obtained. Data collection process Before the survey, the purpose of this study was clearly explained to each participant to ensure voluntary participation. Participants then signed the informed consent form and were assured that their data would remain anonymous and confidential. They were also informed of their right to withdraw from the study at any time if they felt discomfort. Once informed consent was obtained, the questionnaires were distributed to participants, who were trained by the research staff to complete the questionnaires following a standardized guideline. It took approximately 10 min per participant to complete the questionnaires. Throughout the process, participants were encouraged to ask questions as needed to ensure accurate responses and minimize invalid data. Afterward, the questionnaires were retrieved on-site to verify their completeness and accuracy. All data were used exclusively for scientific research and maintained under strict anonymity and confidentiality. Measures Demographic and clinical characteristics Socio-demographic and clinical information was collected using a standardized self-reported questionnaire. Demographic data included age, gender, education, occupation, marital status, residency situation, family per capita monthly income, medical expense burden, systemic comorbidities (i.e., hypertension, diabetes, coronary artery disease, arthritis and obstructive pulmonary disease). Disease-related data included: course of disease, best-corrected visual acuity (BCVA), intraocular pressure (IOP), mean deviation of visual field deficiency (VF MD), family history of glaucoma, history of glaucoma surgery, and number of antiglaucoma drops. BCVA, IOP, and VF MD were recorded separately for each eye. Measurement of fear of progression The Fear of Progression Questionnaire-Short Form (FoP-Q-SF) was developed by Mehnert and Herschbach [25] in 2006. The scale was translated into Chinese by Wu et al. [26] in 2015, and the Cronbach’s α was 0.883. The scale is used to assess the fear of glaucoma progression across 12 items. Each item is assigned a score of 1 (never) to 5 (always). The total score ranges from 12 to 60, with higher scores reflecting greater fear of progression. A score of 34 or higher indicates psychological dysfunction. Cronbach’s α of this scale was 0.900 in our study population, demonstrating good internal consistency. Measurement of glaucoma symptom The Glaucoma Symptom Scale Questionnaire (GSS) was developed by Brian L. Lee [27] and translated into Chinese by Yang et al. in 2023 [28]. The Chinese version of the GSS questionnaire has demonstrated good reliability, validity and practicability. The questionnaire consists of 10 symptoms, including six non-visual symptoms (SYMP-6 dimension) and four visual symptoms (FUNC-4 dimension). For each eye, a 5-point scale is used, ranging from 0 (symptoms absent) to 4 (symptoms present and very bothersome). This score is then converted to a 0 to 100 scale, where 0 indicates absence of a problem and 100 indicates a very bothersome problem. The final GSS score is the un-weighted average of the responses to all 10 items, averaged between both eyes. Similarly, subscale scores are calculated as the unweighted average of all items within each subscale, averaged between both eyes. A higher score indicates more severe symptoms in glaucoma patients. In the current study, Cronbach’s α for this scale was 0.839. Measurement of illness perception The Brief Illness Perception Questionnaire (BIPQ) was designed by Broadbent in 2006 [29] as a valid and reliable tool to assess illness perceptions across various patient groups. The Chinese version of the BIPQ has demonstrated good reliability, validity and practicability in groups such as patients with hypertension and hematologic malignancies [30, 31]. The scale consists of 9 items, including illness consequences, timeline, personal control, treatment control, identity, coherence, concern, emotional response and causal representation. The final question is open-ended, while the other eight questions are scored on a 0 to 10 scale. Items related to personal control, treatment control and coherence items are reverse scored. The scores for the eight items are summed together to generate a total BIPQ score, ranging from 0 to 80. A higher score indicates a greater perceived psychological burden associated with the illness. In our study, the Cronbach’s α was 0.689, slightly below the conventional threshold, which reflects the multidimensional nature of the instrument. Data analysis LPA was performed using Mplus 8.3 to investigate the optimal number of latent profiles characterizing patients’ fear of progression. Models ranging from one to five profiles were evaluated based on the Akaike information criterion (AIC), Bayesian information criterion (BIC), adjusted Bayesian information criterion (aBIC) and entropy value. Lower AIC, BIC, aBIC, along with a higher entropy value (> 0.8) indicated better model fit [14, 15]. Additionally, the Lo-Mendell-Rubin adjusted Likelihood Ratio Test (LMRT) and Bootstrap Likelihood Ratio Test (BLRT) were used to compare the fit between models with k and k-1 classes. A significant difference (p < 0.05) indicated that the k-profile model provided a better fit than the k-1 profile model [14, 15]. Following the recommendation of Nylund et al. and other studies [14, 32], model selection was based on the following criteria: (1) significant LMRT and BLRT; (2) low values of sample-size adjusted BIC; (3) high entropy value (> 0.8), and (4) interpretability. After determining the optimal profile model, SPSS 26.0 was used to complete statistics analysis. Categorical variables were described as frequencies and percentages. Continuous variables following a normal distribution were described using mean and standard deviation (SD), while those not following a normal distribution were described using median and interquartile range (IQR). Differences in socio-demographic and glaucoma-related characteristics across profiles were analyzed using chi-square (χ2) tests for categorical variables and analysis of variance (ANOVA) for continuous variables. Variables with a p < 0.1 in the univariate analysis were included in the ordinal logistic regression analysis to identify predictors of the different fear of progression profiles. Statistical significance was set at p < 0.05. To ensure accuracy, all statistical analyses were reviewed by an expert statistician prior to submission. Results Participants Two hundred and twenty-seven participants were eligible for inclusion, and all of participants provided complete responses to the questionnaire survey, with a response rate of 100%. No participants declined to participate, and no questionnaires were excluded due to invalid data. Demographic and clinical characteristics This study included 227 participants with glaucoma, with a mean age of 47.26 ± 15.58 years. A detailed summary of their demographic and glaucoma-related characteristics is provided in Table 1. Of the participants, 44.1% (n = 100) were male. The majority were unemployed or retired (61.7%, n = 140), married (79.3%, n = 180), and lived with family members (90.7%, n = 206). More than half of the participants reported a family per capita monthly income below 8,000 CNY, and 15.0% (n = 34) indicated they had severe financial burden from medical expenses. 17.6% (n = 40) of patients had a BCVA < 0.3 in their better eye, while 65.2% (n = 148) of patients had a BCVA < 0.3 in their worse eye. The average IOP in the better eye was 14.54 ± 6.17 mmHg, with a mean VF MD of -8.88 ± 10.06 dB in the visual field. Meanwhile, the average IOP in the worse eye was 26.84 ± 12.00 mmHg, with a mean VF MD of -18.56 ± 10.99 dB. A family history of glaucoma was reported by 19.4% (n = 44) of participants. Additionally, 33% (n = 75) had previously undergone glaucoma surgery, and 41.9% (n = 95) were using two or more ocular hypotensive medications for treatment. 77 (33.9%) patients had comorbid systemic diseases. Table 1Sample demographics and clinical characteristics (N = 227)VariablesFrequency/Mean/MedianPercentage (%) /SD/IQRAge (years)47.2615.58Gender Male10044.1 Female12755.9Education Junior school or lower8738.3 Senior and technical school9742.7 College or above4318.9Occupation Unemployment7633.5 Retirement6428.2 Employment8738.3Marital status Unmarried/Separated/widowed4720.7 Married18079.3Residency situation Solitude219.3 Live with family20690.7Family per capita monthly income (CNY) ≤ 50006629.1 5001 ~ 80008135.7 8001 ~ 10,0004720.7 > 10,0003214.1Medical expense burden None6428.2 Mild7633.5 Moderate5222.9 Severe3415.0Course of disease(Month)121,19BCVA (better eye) < 0.34017.6 ≥ 0.318782.4BCVA (worse eye) < 0.314865.2 ≥ 0.37934.8IOP (better eye, mmHg)14.546.17IOP (worse eye, mmHg)26.8412.00VF MD (better eye, dB) (n = 123)-8.8810.06VF MD (worse eye, dB) (n = 174)-18.5610.99Family history of glaucoma Yes4419.4 No18280.2History of glaucoma surgery Yes7533.0 No15267.0Number of antiglaucoma drops ≤ 113258.1 > 19541.9Systemic comorbidities Yes7733.9 No15066.1Abbreviations: BCVA Best-corrected visual acuity, IOP Intraocular Pressure, MD Mean Deviation, VF Visual Field, SD standard deviation, IQR Interquartile Range Table 1Sample demographics and clinical characteristics (N = 227)VariablesFrequency/Mean/MedianPercentage (%) /SD/IQRAge (years)47.2615.58Gender Male10044.1 Female12755.9Education Junior school or lower8738.3 Senior and technical school9742.7 College or above4318.9Occupation Unemployment7633.5 Retirement6428.2 Employment8738.3Marital status Unmarried/Separated/widowed4720.7 Married18079.3Residency situation Solitude219.3 Live with family20690.7Family per capita monthly income (CNY) ≤ 50006629.1 5001 ~ 80008135.7 8001 ~ 10,0004720.7 > 10,0003214.1Medical expense burden None6428.2 Mild7633.5 Moderate5222.9 Severe3415.0Course of disease(Month)121,19BCVA (better eye) < 0.34017.6 ≥ 0.318782.4BCVA (worse eye) < 0.314865.2 ≥ 0.37934.8IOP (better eye, mmHg)14.546.17IOP (worse eye, mmHg)26.8412.00VF MD (better eye, dB) (n = 123)-8.8810.06VF MD (worse eye, dB) (n = 174)-18.5610.99Family history of glaucoma Yes4419.4 No18280.2History of glaucoma surgery Yes7533.0 No15267.0Number of antiglaucoma drops ≤ 113258.1 > 19541.9Systemic comorbidities Yes7733.9 No15066.1Abbreviations: BCVA Best-corrected visual acuity, IOP Intraocular Pressure, MD Mean Deviation, VF Visual Field, SD standard deviation, IQR Interquartile Range Sample demographics and clinical characteristics (N = 227) Abbreviations: BCVA Best-corrected visual acuity, IOP Intraocular Pressure, MD Mean Deviation, VF Visual Field, SD standard deviation, IQR Interquartile Range LPA of participants LPA was conducted using the twelve items of the FoP-Q-SF, with latent profile models ranging from one to five categories. As the number of categories increased, the AIC, BIC, and aBIC consistently decreased, indicating better model fit. All models demonstrated entropy values above 0.8, suggesting reliable classification accuracy. Notably, the three-profile model showed significant improvement over the two-profile model, as evidenced by both the LMR and BLRT tests. Detailed model fit indices were provided in Table 2. However, transitioning from the three-profile to the four-profile model did not yield further significant improvements. Thus, the three-profile model was the most optimal representation of fear of progression in this study. Based on scores of FoP-Q-SF, we identified three distinct profiles of FoP among the participants (Fig. 1). Class 2, consisting of 108 (47.58%) participants, demonstrated moderate scores across all items, indicating a stable level of fear regarding disease progression. This group was categorized as the “moderate FoP-stable group”. Class 1, comprising 48 (21.14%) participants, showed lower scores overall compared to Class 2. Notably, participants in this group expressed less concern about specific issues, such as item 7 (“It disturbs me that I may have to rely on strangers for activities of daily living”) and item 11 (“I worry about what will become of my family if something should happen to me”). As a result, this group was labeled the “low FoP-supported group”. Class 3, with 71 (31.28%) participants, exhibited heightened concerns about their future employment, as reflected in high scores for item 4 (“The thought that I might become less productive at my job disturbs me”) and item 12 (“The thought that I might not be able to work due to my illness disturbs me”) [33, 34]. This profile was characterized by uncertainty about their career and was therefore categorized as the “high FoP-uncertain group”. Table 2Comparison of fit indices between modelsProfileAICBICaBICLMRT(p)BLRT(p)EntropyProfile prevalance(%)18642.2038724.4028648.339----27875.8208002.5437885.279<0.001<0.000.89345.37/54.6337620.1667791.4147632.9490.041<0.0010.88721.14/47.58/31.2847512.7497728.5217528.8560.071<0.0010.88211.45/37.89/36.56/14.1057463.5637723.8607482.9940.095<0.0010.88711.89/36.56/29.96/10.57/11.01Abbreviations: AIC Akaike information criterion, BIC Bayesian information criterion, aBIC adjusted Bayesian information criterion, LMRT Lo-Mendell-Rubin adjusted Likelihood Ratio Test, BLRT Bootstrap Likelihood Ratio Test Table 2Comparison of fit indices between modelsProfileAICBICaBICLMRT(p)BLRT(p)EntropyProfile prevalance(%)18642.2038724.4028648.339----27875.8208002.5437885.279<0.001<0.000.89345.37/54.6337620.1667791.4147632.9490.041<0.0010.88721.14/47.58/31.2847512.7497728.5217528.8560.071<0.0010.88211.45/37.89/36.56/14.1057463.5637723.8607482.9940.095<0.0010.88711.89/36.56/29.96/10.57/11.01Abbreviations: AIC Akaike information criterion, BIC Bayesian information criterion, aBIC adjusted Bayesian information criterion, LMRT Lo-Mendell-Rubin adjusted Likelihood Ratio Test, BLRT Bootstrap Likelihood Ratio Test Comparison of fit indices between models Abbreviations: AIC Akaike information criterion, BIC Bayesian information criterion, aBIC adjusted Bayesian information criterion, LMRT Lo-Mendell-Rubin adjusted Likelihood Ratio Test, BLRT Bootstrap Likelihood Ratio Test Fig. 1Three latent profiles of FoP in glaucoma patients Three latent profiles of FoP in glaucoma patients Predictors of latent profile membership Factors associated with FoP on univariable analysis are detailed in Table 3. Variables with P < 0.100 were found across the three FoP profiles in relation to age (χ² = 7.799, P = 0.099), occupation (χ² = 22.785, P < 0.001), marital status (χ² = 5.788, P = 0.055) and medical expense burden (χ² = 11.245, P = 0.081), as shown by the Chi-squared test. One-way ANOVA and Kruskal-Wallis tests also revealed significant differences in several key measures: VF MD in the worse eye (F = 3.551, P = 0.031), GSS total score (H = 10.385, P = 0.006) and BIPQ score (F = 15.752, P < 0.001) across the profiles. To explore these differences further, Ordinal logistic regression was performed with the three FoP profiles as the outcome variables. Significant factors from the univariate analysis were used as predictors. Multiple collinearity diagnosis of variables showed that the VIF values of all variables were ranging from 1.032 to 1.343, indicating that there is no collinearity between variables. The results of ordinal logistic regression, summarized in Table 4, highlight key factors influencing the patterns of FoP. Patients aged 45–59 years showed significantly higher FoP than elderly patients (≥ 60 years) (OR = 2.971, 95% CI = 1.071–8.240). Unemployed patients exhibited a higher likelihood of experiencing elevated FoP (OR = 2.560, 95% CI = 1.203–5.441). Married patients were also more likely to have higher FoP (OR = 2.342, 95% CI = 1.053–5.202). Additionally, patients with a worse VF MD in their worse eye had a higher probability of experiencing elevated FoP (OR = 0.969, 95% CI = 0.942–0.996). Lastly, patients with higher levels of illness perception were at a greater risk of having higher FoP (OR = 1.040, 95% CI = 1.011–1.069). Table 3Univariate analysis of three latent profiles (N = 227)variablesFoPTotal (N = 227)N(%) /mean(SD)/median (IQR)Class 1 (N = 48)N(%) /mean(SD)/median (IQR)Class 2 (N = 108)N(%) /mean(SD)/median (IQR)Class 3 (N = 71)N(%)/mean(SD)/median (IQR)Statistical values p Age (years)7.799c 0.099 18 ~ 44101 (44.7)20 (41.7)49 (45.4)33 (46.5) 45 ~ 5968 (30.1)9 (18.8)36 (33.6)23 (32.4) ≥ 6057 (25.2)19 (39.6)23 (21.5)15 (21.1)Gender3.278c0.194 Male100 (44.1)23 (47.9)52 (48.1)25 (35.2) Female127 (55.9)25 (52.1)56 (51.9)46 (64.8)Education0.993c0.911 Junior school or lower87 (38.3)17 (35.4)42 (38.9)28 (39.4) Senior and technical school97 (42.7)21 (43.8)44 (40.7)32 (45.1) College or above43 (18.9)10 (20.8)22 (20.4)11 (15.5)Occupation22.785c < 0.001 Unemployment76 (33.5)8 (16.7)34 (31.5)34 (47.9) Retirement64 (28.2)22 (45.8)22 (20.4)20 (28.2) Employment87 (38.3)18 (37.5)52 (48.1)17 (23.9)Marital status5.788c 0.055 Unmarried/Separated/widowed47 (20.7)13 (27.1)26 (24.1)8 (11.3) Married180 (79.3)35 (72.9)82 (75.9)63 (88.7)Residency situation0.201b0.956 Solitude21 (9.3)4 (8.3)11 (10.2)6 (8.5) Live with family206 (90.7)44 (91.7)97 (89.8)65 (91.5)Family per capita monthly income (CNY)9.312c0.157 ≤ 500066 (29.2)16 (34.0)27 (25.0)23 (32.4) 5001 ~ 800081 (35.8)16 (34.0)46 (42.6)19 (26.8) 8001 ~ 10,00047 (20.8)9 (19.1)17 (15.7)21 (29.6) > 10,00031 (14.2)6 (12.8)18 (16.7)8 (11.3)Medical expense burden11.245c 0.081 None64 (28.3)19 (40.4)26 (24.1)19 (26.8) Mild76 (33.6)14 (29.8)40 (37.0)22 (31.0) Moderate52 (23.0)6 (12.8)31 (28.7)15 (21.1) Severe34 (15.0)8 (17.0)11 (10.2)15 (21.1)Systemic comorbidities0.511c0.774 Yes77 (33.9)16 (33.3)39 (36.1)22 (31.0) No150 (66.1)32 (66.7)69 (63.9)49 (69.0)Family history of glaucoma2.613c0.271 Yes44 (19.5)13 (27.7)18 (16.7)13 (18.3) No182 (80.5)34 (72.3)90 (83.3)58 (81.7)History of glaucoma surgery3.050c0.218 Yes152 (67.0)29 (60.4)70 (64.8)53 (74.6) No75 (33.0)19 (39.6)38 (35.2)18 (25.4)BCVA (better eye)2.846c0.241 < 0.340 (17.6)7 (14.6)16 (14.8)17 (23.9) ≥ 0.3187 (82.4)41 (85.4)92 (85.2)54 (76.1)BCVA (worse eye)3.799c0.150 < 0.3148 (65.2)27 (56.3)69 (63.9)52 (73.2) ≥ 0.379 (34.8)21 (43.8)39 (36.1)19 (26.8)Number of antiglaucoma drops0.254c0.881 ≤ 1132 (58.1)29 (60.4)61 (56.5)42 (59.2) > 195 (41.9)19 (39.6)47 (43.5)29 (40.8)Course of disease(Month)12 (1.00, 49.00)12 (1.25, 48.00)9 (1.00, 43.25)17 (1.00, 67.00)1.228d0.541IOP (better eye, mmHg)14.54 ± 6.1714.65 ± 6.9114.62 ± 5.7214.35 ± 6.370.051a0.950IOP (worse eye, mmHg)26.84 ± 12.0023.67 ± 10.1827.97 ± 11.8127.28 ± 13.152.222a0.111VF MD (better eye, dB)-8.88 ± 10.06-6.17 ± 6.92-8.52 ± 10.33-11.56 ± 11.072.189a0.116VF MD (worse eye, dB)-18.56 ± 10.99-14.49 ± 10.60-18.81 ± 10.92-20.83 ± 10.833.551a 0.031 GSS score22.5(13.75, 37.20)32.5(18.75, 46.25)37.5(22.50, 47.50)32.5(18.75,45.00)10.385d 0.006 BIPQ score55.63 ± 11.7748.90 ± 13.1855.42 ± 10.2360.49 ± 10.7515.752a < 0.001 Variables in bold are those considered statistically significant (P < 0.1)Abbreviations: Class 1 low FoP-supported group, Class 2 moderate FoP-stable group, Class 3 high FoP-uncertain group, BCVA best-corrected visual acuity, IOP intraocular pressure, MD mean deviation, VF visual field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception Questionnaire, SD stand deviation, IQR Interquartile RangeaThe one-way ANOVAbFisher exact probabilitycChi-square testdKruskal-Wallis test Table 3Univariate analysis of three latent profiles (N = 227)variablesFoPTotal (N = 227)N(%) /mean(SD)/median (IQR)Class 1 (N = 48)N(%) /mean(SD)/median (IQR)Class 2 (N = 108)N(%) /mean(SD)/median (IQR)Class 3 (N = 71)N(%)/mean(SD)/median (IQR)Statistical values p Age (years)7.799c 0.099 18 ~ 44101 (44.7)20 (41.7)49 (45.4)33 (46.5) 45 ~ 5968 (30.1)9 (18.8)36 (33.6)23 (32.4) ≥ 6057 (25.2)19 (39.6)23 (21.5)15 (21.1)Gender3.278c0.194 Male100 (44.1)23 (47.9)52 (48.1)25 (35.2) Female127 (55.9)25 (52.1)56 (51.9)46 (64.8)Education0.993c0.911 Junior school or lower87 (38.3)17 (35.4)42 (38.9)28 (39.4) Senior and technical school97 (42.7)21 (43.8)44 (40.7)32 (45.1) College or above43 (18.9)10 (20.8)22 (20.4)11 (15.5)Occupation22.785c < 0.001 Unemployment76 (33.5)8 (16.7)34 (31.5)34 (47.9) Retirement64 (28.2)22 (45.8)22 (20.4)20 (28.2) Employment87 (38.3)18 (37.5)52 (48.1)17 (23.9)Marital status5.788c 0.055 Unmarried/Separated/widowed47 (20.7)13 (27.1)26 (24.1)8 (11.3) Married180 (79.3)35 (72.9)82 (75.9)63 (88.7)Residency situation0.201b0.956 Solitude21 (9.3)4 (8.3)11 (10.2)6 (8.5) Live with family206 (90.7)44 (91.7)97 (89.8)65 (91.5)Family per capita monthly income (CNY)9.312c0.157 ≤ 500066 (29.2)16 (34.0)27 (25.0)23 (32.4) 5001 ~ 800081 (35.8)16 (34.0)46 (42.6)19 (26.8) 8001 ~ 10,00047 (20.8)9 (19.1)17 (15.7)21 (29.6) > 10,00031 (14.2)6 (12.8)18 (16.7)8 (11.3)Medical expense burden11.245c 0.081 None64 (28.3)19 (40.4)26 (24.1)19 (26.8) Mild76 (33.6)14 (29.8)40 (37.0)22 (31.0) Moderate52 (23.0)6 (12.8)31 (28.7)15 (21.1) Severe34 (15.0)8 (17.0)11 (10.2)15 (21.1)Systemic comorbidities0.511c0.774 Yes77 (33.9)16 (33.3)39 (36.1)22 (31.0) No150 (66.1)32 (66.7)69 (63.9)49 (69.0)Family history of glaucoma2.613c0.271 Yes44 (19.5)13 (27.7)18 (16.7)13 (18.3) No182 (80.5)34 (72.3)90 (83.3)58 (81.7)History of glaucoma surgery3.050c0.218 Yes152 (67.0)29 (60.4)70 (64.8)53 (74.6) No75 (33.0)19 (39.6)38 (35.2)18 (25.4)BCVA (better eye)2.846c0.241 < 0.340 (17.6)7 (14.6)16 (14.8)17 (23.9) ≥ 0.3187 (82.4)41 (85.4)92 (85.2)54 (76.1)BCVA (worse eye)3.799c0.150 < 0.3148 (65.2)27 (56.3)69 (63.9)52 (73.2) ≥ 0.379 (34.8)21 (43.8)39 (36.1)19 (26.8)Number of antiglaucoma drops0.254c0.881 ≤ 1132 (58.1)29 (60.4)61 (56.5)42 (59.2) > 195 (41.9)19 (39.6)47 (43.5)29 (40.8)Course of disease(Month)12 (1.00, 49.00)12 (1.25, 48.00)9 (1.00, 43.25)17 (1.00, 67.00)1.228d0.541IOP (better eye, mmHg)14.54 ± 6.1714.65 ± 6.9114.62 ± 5.7214.35 ± 6.370.051a0.950IOP (worse eye, mmHg)26.84 ± 12.0023.67 ± 10.1827.97 ± 11.8127.28 ± 13.152.222a0.111VF MD (better eye, dB)-8.88 ± 10.06-6.17 ± 6.92-8.52 ± 10.33-11.56 ± 11.072.189a0.116VF MD (worse eye, dB)-18.56 ± 10.99-14.49 ± 10.60-18.81 ± 10.92-20.83 ± 10.833.551a 0.031 GSS score22.5(13.75, 37.20)32.5(18.75, 46.25)37.5(22.50, 47.50)32.5(18.75,45.00)10.385d 0.006 BIPQ score55.63 ± 11.7748.90 ± 13.1855.42 ± 10.2360.49 ± 10.7515.752a < 0.001 Variables in bold are those considered statistically significant (P < 0.1)Abbreviations: Class 1 low FoP-supported group, Class 2 moderate FoP-stable group, Class 3 high FoP-uncertain group, BCVA best-corrected visual acuity, IOP intraocular pressure, MD mean deviation, VF visual field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception Questionnaire, SD stand deviation, IQR Interquartile RangeaThe one-way ANOVAbFisher exact probabilitycChi-square testdKruskal-Wallis test Univariate analysis of three latent profiles (N = 227) Variables in bold are those considered statistically significant (P < 0.1) Abbreviations: Class 1 low FoP-supported group, Class 2 moderate FoP-stable group, Class 3 high FoP-uncertain group, BCVA best-corrected visual acuity, IOP intraocular pressure, MD mean deviation, VF visual field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception Questionnaire, SD stand deviation, IQR Interquartile Range aThe one-way ANOVA bFisher exact probability cChi-square test dKruskal-Wallis test Table 4Ordinal logistic regression analysis of factors influencing the potential profile of FoP (N = 227)VariablesβSE p OR95% CI for ORLowerUpperAge (years) 18–440.9970.6060.1002.7100.8278.882 45–591.0890.521 0.036 2.9711.0718.240 ≥ 60a------Occupation Unemployment0.9400.385 0.015 2.5601.2035.441 Retirement0.3730.5480.4961.4520.4964.250 Employmenta------Marital status (married)0.8510.407 0.037 2.3421.0535.202Medical expense burden None-0.2440.5520.6580.7830.2662.309 Mild-0.1990.5260.7070.8200.2932.300 Moderate0.0340.5350.9491.0350.3632.954 Severea------VF MD (worse eye)-0.0320.014 0.026 0.9690.9420.996GSS score0.0050.0080.5591.0050.9891.020BIPQ score0.0390.014 0.007 1.0401.0111.069Variables in bold are those considered statistically significant (P < 0.05)Abbreviations: MD Mean Deviation, VF Visual Field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception QuestionnaireaReference category Table 4Ordinal logistic regression analysis of factors influencing the potential profile of FoP (N = 227)VariablesβSE p OR95% CI for ORLowerUpperAge (years) 18–440.9970.6060.1002.7100.8278.882 45–591.0890.521 0.036 2.9711.0718.240 ≥ 60a------Occupation Unemployment0.9400.385 0.015 2.5601.2035.441 Retirement0.3730.5480.4961.4520.4964.250 Employmenta------Marital status (married)0.8510.407 0.037 2.3421.0535.202Medical expense burden None-0.2440.5520.6580.7830.2662.309 Mild-0.1990.5260.7070.8200.2932.300 Moderate0.0340.5350.9491.0350.3632.954 Severea------VF MD (worse eye)-0.0320.014 0.026 0.9690.9420.996GSS score0.0050.0080.5591.0050.9891.020BIPQ score0.0390.014 0.007 1.0401.0111.069Variables in bold are those considered statistically significant (P < 0.05)Abbreviations: MD Mean Deviation, VF Visual Field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception QuestionnaireaReference category Ordinal logistic regression analysis of factors influencing the potential profile of FoP (N = 227) Variables in bold are those considered statistically significant (P < 0.05) Abbreviations: MD Mean Deviation, VF Visual Field, GSS Glaucoma Symptom Scale, BIPQ Brief Illness Perception Questionnaire aReference category Discussion Glaucoma, a progressive and irreversible cause of vision loss, imposes a significant and prolonged psychological burden on patients [4]. Despite its impact, few studies have focused on the FoP among glaucoma patients. This study explored the status and associated factors of FoP, using LPA to identify three patient groups: low FoP-supported group, moderate FoP-stable group, and high FoP-uncertain group. Our results revealed that a considerable proportion of glaucoma patients experience moderate to high levels of FoP, consistent with findings from other chronic disease populations [11, 15]. This finding offered a novel perspective in the field of glaucoma, highlighting the individual differences in FoP within populations, rather than treating patients as a homogenous group. Furthermore, ordinal logistic regression identified middle age, unemployment, being married, poorer VF MD scores in the worse eye, and higher levels of illness perception as significant predictors of elevated FoP. This study provided valuable insights for clinical practice, assisting clinicians in identifying patients at greater risk of elevated FoP and designing tailored intervention strategies. The low FoP-supported group comprised 21.14% of the sample and reported lower scores on items about relying on others for daily activities and the impact on their family, indicating fewer concerns about dependency and family burden. This group showed minimal worry about disease progression, potentially reflecting successful adaptation to illness threats through a more supportive environment and effective coping strategies. From a resilience perspective, these patients appeared to effectively manage their emotional responses to disease-related stress, likely due to robust support systems [35]. Although this group had a lower level of FoP, healthcare professionals should continuously monitor their psychological status to prevent overlooking risks and psychological needs during treatment. The moderate FoP-stable group accounted for 47.58% of the sample and showed intermediate scores across items. This group exhibited a stable moderate level of anxiety, with concerns about disease progression. The patients scored higher on items related to physical symptoms of anxiety and worries about losing the ability to pursue hobbies. This result indicated patients’ concerns about the potential impact of the disease on daily activities and quality of life. This group appeared to balance concern with maintaining normal functioning, suggesting active self-monitoring. Interventions for this group should focus on improving disease understanding, strengthening emotional regulation, and promoting adaptive coping strategies, such as through psychoeducation and resilience training, to help effectively manage anxiety [35]. The high FoP-uncertain group represented 31.28% of the sample and reported high scores across all items, exhibiting substantial anxiety about disease progression. Their concern about work was particularly severe, including reduced productivity and the inability to continue working. This may be attributed to the poor socio-economic status of patients in this profile, with a larger proportion of unemployment (47.9%) and low family per capita monthly income of < 8000 CNY (59.2%). This group’s fear centered around professional identity and career stability, likely shaped by societal emphasis on productivity. These concerns were linked with higher levels of FoP, as these patients feared the consequences of disease progression on their livelihood and social role. Additional concerns, such as limitations in daily activities and potential side effects of treatment, further increased psychological stress. These findings suggest that targeted interventions, including vocational support and psychological counseling, are needed to address work-related fears and support patients’ sense of purpose and well-being. Age and occupation played crucial roles in FoP among patients with chronic diseases [14]. In this study, unemployed patients reported higher levels of FoP, consistent with findings from Jung et al. [36] but differing from Li et al. [14], who suggested that unemployed individuals experienced lower FoP due to reduced disease awareness. Additionally, our research found that patients aged 45–59 years experienced higher levels of FoP compared to older patients, consistent with previous studies [10, 15]. Middle-aged adults, often in the prime of their careers, bore substantial social and financial responsibilities, particularly when supporting their families. For unemployed glaucoma patients, this age group faced added strain, including the challenge of affording ongoing care, such as medications, frequent testing, and surgeries. These patients worried about the progression of their condition, which not only heightened their FoP but also perpetuated a cycle of unemployment and financial hardship [19, 37]. Furthermore, unemployment led to reduced social engagement and limited access to community or rehabilitation programs, which in turn exacerbated FoP [38, 39]. Given these factors, healthcare providers should assess patients’ work-related challenges and consider referring them to Visual Impairment Rehabilitation Centers. These centers can help patients develop self-care skills and improve their ability to work, thereby facilitating their reintegration into society. The relationship between marital status and FoP remained inconclusive in previous research [10, 40]. While some studies found no significant association, Koch et al. reported higher levels of FoP among married patients [40], a finding consistent with our result. Several factors may explain this observation. First, married individuals often assumed the role of family providers, bearing greater responsibilities within their households [41]. Glaucoma progression, which led to reduced physical function, limited social activity, and diminished independence and quality of life [42], could hinder their ability to fulfill these roles. The inability to meet familial obligations may cause feelings of guilt, self-blame, and a threatened sense of personal identity, further intensifying FoP [43]. Second, married patients were more likely to have children, and previous research indicated that female patients were more concerned about how their health impacts their children and close family members [44]. This heightened concern can amplify FoP. Finally, recent studies suggested that some patients’ FoP stemmed from fears of becoming unable to care for their loved ones or the prospect of leaving them alone [45]. These emotional concerns, combined with the progressive and irreversible nature of glaucoma, may contribute to elevated FoP levels among married individuals. For married patients, spouses often act as primary caregivers. Addressing both the patient and their spouse as a unit can effectively reduce FoP [15]. Education for spouses and other family members is essential, as their active involvement can provide critical emotional and practical support. For example, family members can assist by reminding patients to take their medications and tracking their daily condition, helping patients better manage their disease. Moreover, mindfulness based cognitive therapy can be conducted to relieve patients’ FoP [46]. In our study, illness perception was positively correlated with the FoP, consistent with findings from previous research [16, 31, 47]. Additionally, VF MD scores, were more closely linked to patients’ perceptions of their condition [48]. Our finding revealed that worse VF MD scores were associated with higher levels of FoP, reflecting greater visual function loss [49], and an increased burden of illness perception. This result was supported by an earlier study showing that visual impairment exacerbated negative illness perception [50]. Negative illness perceptions, in turn, could trigger feelings of helplessness, anxiety, and depression [31]. Patients with such perceptions may avoid seeking help or accepting their condition, further exacerbating stress and FoP. Over time, persistent FoP could reinforce maladaptive coping strategies, deepening negative views of the illness and perpetuating psychological distress [51]. Additionally, patients with elevated FoP may exhibit diminished medication self-efficacy and poor treatment adherence, driven by the belief that therapeutic interventions are ineffective against the advancing disease. This creates a detrimental feedback loop, further worsening their illness perception, visual function loss and health behaviors. These findings highlight the critical role of illness perception in shaping patients’ psychological responses to glaucoma progression, and its bidirectional relationship with FoP. Healthcare providers must address patients’ illness perceptions, recognizing that these perceptions may vary depending on the stage of the disease, as reflected by VF MD scores [49]. Educational interventions can help patients gain a better understanding of glaucoma and improve their treatment adherence. Psychological approaches, including cognitive behavioral therapy and stress-resilience training, can alleviate FoP and its associated symptoms, improving overall well-being [35, 41]. Remarkably, some findings were non-significant, such as the lack of correlation between the GSS scales, VF MD in better eye, and FoP. The GSS questionnaire consists of two dimensions: SYMP-6 and FUNC-4. In this study, we analyzed these subscales separately rather than using the total GSS score. However, this approach did not yield statistically significant results. This lack of association may be due to the asynchrony between acute physical discomfort and long-term fear of progression. While the GSS primarily captures short-term ocular surface symptoms (e.g., burning, itching, blurred vision) over the past month, FoP is a long-term concern about future vision loss. Additionally, during the chronic or clinical remission stages of glaucoma, patients may remain asymptomatic in terms of ocular discomfort, but still experience intense anxiety about disease progression. This suggests that in glaucoma, FoP is driven more by the threat of functional impairment than by immediate somatic symptoms. In contrast to the GSS, VF MD is an objective indicator to reflect visual symptom. Previous study has shown that patients with more severe VF MD in better eye are more concerned with social-economic factors, which contribute to their overall quality of life [52]. However, in glaucoma, the clinical status of more severe VF MD in worse eye, rather than the better eye, may reflect disease progression and be the primary factor contributing to negative perceptions, which in turn leads to higher levels of FoP. Limitations Despite the valuable insights gained, our study has several limitations. First, the use of a convenience sampling method resulted in demographic variations due to the selection of specific regions, which may limit the generalizability of the findings. Future research could benefit from multi-center studies with larger sample sizes to enhance the representativeness and applicability of the results across glaucoma populations from different geographical areas. Second, a longitudinal design would be necessary to explore the directionality and dynamic evolution of the observed relationships over time. Third, as some data were collected through self-reported questionnaires, recall and comprehension biases may have influenced the accuracy of the responses. Furthermore, several potential factors, such as social support, distress disclosure, binocular visual field sensitivity and other disease-related variables, were not examined in this study. Future research should consider these factors and investigating how they influence FoP in different glaucoma subtypes to develop more targeted and effective care strategies. Conclusions By using the LPA technique, we identified three distinct FoP profiles among glaucoma patients: the “low FoP-supported group”, “moderate FoP-stable group”, and “high FoP-uncertain group”. Middle age, unemployment and being married further exacerbate FoP, particularly in patients worried about their disability to work and support their families. More severe visual field damage and perceived illness burden are also closely linked to higher FoP levels. These findings highlight the importance of holistic care that addresses both the physical and psychological burden of glaucoma. Healthcare providers should implement tailored interventions, including work-related support, family-centered education, and psychological counseling, to help patients reduce their FoP. Supplementary Information Supplementary Material 1. Supplementary Material 1.